Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency

Area of Science:

• Nanotechnology
• Photodynamic Therapy
• Drug Delivery Systems

Background:

• Photosensitizer hydrophobicity can lead to aggregation, reducing photodynamic activity.
• Nanocarrier systems offer a solution to improve photosensitizer delivery and efficacy.
• Hypericin is a photosensitizer with potential for photodynamic therapy.

Purpose of the Study:

• To prepare and characterize hypericin-loaded solid lipid nanoparticles (Hy-SLN).
• To evaluate the potential of Hy-SLN for photodynamic therapy (PDT).

Main Methods:

• Solid lipid nanoparticles (SLN) were prepared using ultrasonication.
• Physicochemical properties, including particle size, polydispersity index, entrapment efficiency (EE%), and drug loading capacity, were determined.
• Photodynamic efficiency was assessed by measuring the photodecomposition rates of singlet oxygen trapping reagents and evaluating cell uptake and cytotoxicity.

Main Results:

• Hy-SLN exhibited a mean particle size of 153 nm and a low polydispersity index (0.28).
• High entrapment efficiency (>80%) and drug loading capacity (5.22% w/w) were achieved.
• Encapsulation increased photodecomposition rate constants by 60% and 50%, enhanced cell uptake by 30%, and improved cytotoxicity by 26%.

Conclusions:

• Hy-SLN formulation successfully improved hypericin's solubility and photodynamic efficiency.
• The enhanced properties suggest Hy-SLN is a promising candidate for photodynamic therapy applications.
• Solid lipid nanoparticles provide an effective platform for delivering hydrophobic photosensitizers like hypericin.